Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Alvarez-Jimenez

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 20, 2016
Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to goSven C van Dijkman, Ricardo Alvarez-Jimenez, Meindert Danhof, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 2, 2019
Mathematical modeling of the glucagon challenge testSaeed Masroor, Marloes G J van Dongen, Ricardo Alvarez-Jimenez, et al.
Critical Care (London, England)|August 6, 2021
Breathing variability-implications for anaesthesiology and intensive careOscar F C van den Bosch, Ricardo Alvarez-Jimenez, Harm-Jan de Grooth, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 16, 2019
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge modelAnne Catrien Baakman, Ricardo Alvarez-Jimenez, Gordon Loewen, et al.
Scientific Reports|July 20, 2017
EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's diseaseSonja Simpraga, Ricardo Alvarez-Jimenez, Huibert D Mansvelder, et al.
British Journal of Clinical Pharmacology|June 9, 2016
Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjectsRicardo Alvarez-Jimenez, Geert Jan Groeneveld, Joop M A van Gerven, et al.
Journal of Visualized Experiments : Jove|February 26, 2019
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug DevelopmentEllen P Hart, Ricardo Alvarez-Jimenez, Esther Davidse, et al.
British Journal of Clinical Pharmacology|January 11, 2018
Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responsesRicardo Alvarez-Jimenez, Ellen P Hart, Samantha Prins, et al.
Anesthesiology|December 1, 2021
Dexmedetomidine Clearance Decreases with Increasing Drug Exposure: Implications for Current Dosing Regimens and Target-controlled Infusion Models Assuming Linear PharmacokineticsRicardo Alvarez-Jimenez, Maud A S Weerink, Laura N Hannivoort, et al.
Journal of Psychopharmacology (Oxford, England)|December 9, 2016
Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulationRicardo Alvarez-Jimenez, Anne Catrien Baakman, Jasper Stevens, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|July 20, 2016
Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to goSven C van Dijkman, Ricardo Alvarez-Jimenez, Meindert Danhof, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 2, 2019
Mathematical modeling of the glucagon challenge testSaeed Masroor, Marloes G J van Dongen, Ricardo Alvarez-Jimenez, et al.
Critical Care (London, England)|August 6, 2021
Breathing variability-implications for anaesthesiology and intensive careOscar F C van den Bosch, Ricardo Alvarez-Jimenez, Harm-Jan de Grooth, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 16, 2019
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge modelAnne Catrien Baakman, Ricardo Alvarez-Jimenez, Gordon Loewen, et al.
Scientific Reports|July 20, 2017
EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's diseaseSonja Simpraga, Ricardo Alvarez-Jimenez, Huibert D Mansvelder, et al.
British Journal of Clinical Pharmacology|June 9, 2016
Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjectsRicardo Alvarez-Jimenez, Geert Jan Groeneveld, Joop M A van Gerven, et al.
Journal of Visualized Experiments : Jove|February 26, 2019
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug DevelopmentEllen P Hart, Ricardo Alvarez-Jimenez, Esther Davidse, et al.
British Journal of Clinical Pharmacology|January 11, 2018
Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responsesRicardo Alvarez-Jimenez, Ellen P Hart, Samantha Prins, et al.
Anesthesiology|December 1, 2021
Dexmedetomidine Clearance Decreases with Increasing Drug Exposure: Implications for Current Dosing Regimens and Target-controlled Infusion Models Assuming Linear PharmacokineticsRicardo Alvarez-Jimenez, Maud A S Weerink, Laura N Hannivoort, et al.
Journal of Psychopharmacology (Oxford, England)|December 9, 2016
Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulationRicardo Alvarez-Jimenez, Anne Catrien Baakman, Jasper Stevens, et al.
Pageof 2